2-amino-2-(hydroxymethyl)propane-1,3-diol hydrochloride

Dermal absorption

Administrative data

Endpoint:

dermal absorption in vitro / ex vivo

Type of information:

experimental study

Adequacy of study:

key study

Reliability:

2 (reliable with restrictions)

Rationale for reliability incl. deficiencies:

study well documented, meets generally accepted scientific principles, acceptable for assessment

Data source

Reference

Reference Type:

study report

Title:

Unnamed

Year:

1993

Report date:

1993

Materials and methods

Principles of method if other than guideline:

Percutaneous absorption of TRIS HCl was studied in 0.1% and 10% solution in-vitro in 4 samples of human abdominal skin, in a FRANZ diffusion cell.

GLP compliance:

not specified

Test material

Test material information

Constituent 1

Reference substance name:

2-amino-2-(hydroxymethyl)propane-1,3-diol hydrochloride

EC Number:

214-684-5

EC Name:

2-amino-2-(hydroxymethyl)propane-1,3-diol hydrochloride

Cas Number:

1185-53-1

Molecular formula:

C4H11NO3.ClH

IUPAC Name:

2-amino-2-(hydroxymethyl)propane-1,3-diol hydrochloride

Test material form:

solid

Radiolabelling:

yes

Remarks:

carbon-14 labelled solution

Test animals

Species:

other: in-vitro, human abdominal skin in a FRANZ diffusion cell

Strain:

other: in-vitro, human abdominal skin in a FRANZ diffusion cell

Sex:

not specified

Administration / exposure

Type of coverage:

other: not applicable

Vehicle:

not specified

Doses:

- Concentration: 0.1% (1 g/L) and 10% (100 g/L)
- Dose volume: 100 µL

No. of animals per group:

not applicable

Details on in vitro test system (if applicable):

SKIN PREPARATION
- Source of skin: human skin comes from biopsies obtained after plastic surgery of the abdomen
- Type of skin: human abdominal skin
- Preparative technique: skin is cut with a dermatome
- Thickness of skin (in mm): 0.3
- Storage conditions: stored frozen

PRINCIPLES OF ASSAY
- Diffusion cell: FRANZ diffusion cell
- Flow-through system: jacket with double circulation of water surrounds the lower part
- Test temperature: 37 °C

Results and discussion

Percutaneous absorption

Percutaneous absorption 1

Key result

Time point:

24 h

Dose:

100 µl of a 10 % solution

Parameter:

percentage

Absorption:

< 1 %

Percutaneous absorption 2

Key result

Time point:

24 h

Dose:

100 µl of a 1 % solution

Parameter:

percentage

Absorption:

< 1 %

Any other information on results incl. tables

After 24 h, the percutaneous absorption of TRIS-HCl through human abdominal skin in-vitro was very low, regardless of the concentration of the solution. The mean percentages of the applied TRIS HCl dose that had passed into the survival liquid were 0.506 ± 0.765% for the 0.1% solution and 0.797 ± 0.691% for the 10% solution. These differences are not significant.

For both solutions, the maximum value of flux was reached after 4 h and remained essentially constant during the rest of the experiment. However, the value of flux was about 150 times higher for the 10% solution (6.922 ± 6.179 µg/cm2/h) than for the 0.1% solution (0.039 ± 0.052 µg/cm2/h).

After washing, the retention of the test substance in the epidermis and dermis was low: For the 0.1% solution, 0.14 ± 0.19% TRIS HCl remained in the epidermis and 0.69 ± 1.33% in the dermis. For the 10% solution, 0.13 ± 0.21% TRIS HCl was detected in the epidermis and 0.22 ± 0.21% in the dermis. Therefore, the test substance is not retained in the horny layer (epidermis).

The test substance was almost totally eliminated by washing the skin after 24 h. For the 0.1% solution, 91.13 ± 4.67% TRIS HCl was found in the washing waters and for the 10% solution, a quantity of 90.45 ± 4.06%.

However, significant differences in permeability from one skin sample to the other were recorded. (The experiments were carried out on 4 skin samples of different origin: mulatto skin; skin 2 and 3: white skin.) The differences of the individual measurements of the skin samples were lower for the 0.1% solution.

At the end of the 24 h, regardless of the concentration of the solution, the radioactivity found in the epidermis and the dermis was low (less than 1% of the applied dose) and the washing waters contained more than 90% of the applied dose.